Celgene is a biopharmaceutical company that focuses on discovering, developing, and commercializing innovative therapies for the treatment of cancer and immune-inflammatory diseases. The company serves patients and healthcare providers globally, operating in the highly competitive biopharmaceutical market. Celgene's business model revolves around extensive research and development (R&D) to create groundbreaking treatments, which are then brought to market through rigorous clinical trials and regulatory approvals. Revenue is primarily generated through the sale of proprietary drugs and therapies, as well as through strategic partnerships and collaborations with other pharmaceutical companies. The company also invests heavily in expanding its product pipeline to ensure long-term growth and sustainability.

Keywords: biopharmaceutical, cancer, immune-inflammatory, therapies, R&D, clinical trials, proprietary drugs, healthcare, innovation, global.